2008•Chinese Journal of Modern Drug ApplicationRequires access

Bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers

Yang Shui-yua

Open publisher page 0 citations

Abstract

Objective To inspect the bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers.Methods A single(2 g)and multiple(1 g)oral of Enteric-coated Tablets and reference tablets were given to 20 healthy male cvolunteers according to randomized crossover design.Tinidaxole in plasma was determined by HPLC methods.The pharmacokinetic parameters and bioavailability of and reference tables.Results after a single oral of 2 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(881.7±147.5)and(974.5±146.9)mg/(h·L),Cmax was(33.83±6.50)and(47.94±8.68)mg/L,tmax was(10.60±1.93)and(1.63±0.46)h,respectively.The relative bioavailability of Enteric-coated Tablets was(90.91±11.29)%.After multiple oral administration 1 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(1277.9±289.8)and(1191.6±288.0)mg/(h·L),Cmax was(47.74±10.34)and(55.14±9.01)mg/L,tmax was(10.06±1.86)and(1.44±0.64)h,respectively.The relative bioavailability of Enteric-coated Tablets was(109.55±20.58)%.Conclusion The 2 preparations are bioequivalent.

About this research paper

What this paper is about

Objective To inspect the bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers.Methods A single(2 g)and multiple(1 g)oral of Enteric-coated Tablets and reference tablets were given to 20 healthy male cvolunteers according to randomized crossover design.Tinidaxole in plasma was determined by HPLC methods.The pharmacokinetic parameters and bioavailability of and reference tables.Results after a single oral of 2 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(881.7±147.5)and(974.5±146.9)mg/(h·L),Cmax was(33.83±6.50)and(47.94±8.68)mg/L,tmax was(10.60±1.93)and(1.63±0.46)h,respectively.The relative bioavailability of Enteric-coated Tablets was(90.91±11.29)%.After multiple oral administration 1 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(1277.9±289.8)and(1191.6±288.0)mg/(h·L),Cmax was(47.74±10.34)and(55.14±9.01)mg/L,tmax was(10.06±1.86)and(1.44±0.64)h,respectively.The relative bioavailability of Enteric-coated Tablets was(109.55±20.58)%.Conclusion The 2 preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To inspect the bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers.Methods A single(2 g)and multiple(1 g)oral of Enteric-coated Tablets and reference tablets were given to 20 healthy male cvolunteers according to randomized crossover design.Tinidaxole in plasma was determined by HPLC methods.The pharmacokinetic parameters and bioavailability of and reference tables.Results after a single oral of 2 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(881.7±147.5)and(974.5±146.9)mg/(h·L),Cmax was(33.83±6.50)and(47.94±8.68)mg/L,tmax was(10.60±1.93)and(1.63±0.46)h,respectively.The relative bioavailability of Enteric-coated Tablets was(90.91±11.29)%.After multiple oral administration 1 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(1277.9±289.8)and(1191.6±288.0)mg/(h·L),Cmax was(47.74±10.34)and(55.14±9.01)mg/L,tmax was(10.06±1.86)and(1.44±0.64)h,respectively.The relative bioavailability of Enteric-coated Tablets was(109.55±20.58)%.Conclusion The 2 preparations are bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Cmax, Pharmacokinetics, Enteric coated, Enteric coating, Crossover study, Dosage form

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers — Research Paper | ScholarLens